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Abstract
This exploratory and retrospective analysis compared fMRI and cognitive data from nine HT-naïve
women to data from women exposed to either opposed CEE (N=10) or opposed estradiol (N=4).
These preliminary data suggested that exposure to either form of HT was associated with healthier
fMRI response; however, CEE-exposed women exhibited poorer memory performance than either
HT-naïve or estradiol-exposed subjects. These preliminary findings emphasize the urgency to
characterize differential neural effects of various HTs.
INTRODUCTION
Findings from an ancillary study of the WHI, the WHI Memory Study (WHIMS),1, 2 revealed
a potential cognitive harm associated with a common postmenopausal hormone therapy (HT),
opposed conjugated equine estrogen (CEE). These findings were in sharp contrast to extensive
data suggesting estrogen’s neuroprotective and neurotropic effects.3 The discrepancy between
the findings of basic science and the WHIMS highlighted the many unanswered questions
concerning the effects of HT and menopause upon the human CNS.
One post-WHIMS theory proposes that various HT formulations exhibit differential
neuroefficacy. This exploratory report examined the effect of exposure to one of two forms of
HT, opposed CEE or opposed estradiol, versus no exposure to HT. Specifically this study
explored the effect of long-term HT, initiated at menopause on cerebral response during an




Subjects came from a pool of 42 women, enrolled as controls for a study examining the effects
of parental history on risk for developing AD. The 23 (54.8%) eligible subjects had intact
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ovaries and uterus, and were postmenopausal. Mean age was 58.5 years (SD 4.7). At the time
of scan, two women were on opposed CEE and two on opposed estradiol. The HT regimens
used by participants were standard therapies, initiated around menopause. All participants
provided written informed consent. Exclusions for this study are described elsewhere.4, 5
INDEPENDENT VARIABLES
A three-level HT-status variable was created for exploratory analyses. Ten women were
exposed to opposed CEE and four to opposed estradiol preparations. Nine women were naïve
to HT.
FMRI TASK AND ANALYSES
The fMRI task is described in detail elsewhere.4, 5 Briefly, subjects were presented with novel
and previously learned line-drawings. Response to novel items was compared to activation to
previously learned pictures. This difference in activation to novel versus previously learned
items was the condition of interest in this study. The fMRI scanning procedures and individual
subject image analysis are described in a previous publication.4, 5
Between groups comparisons were constrained to a region of interest (ROI), based on
normative activation on this same fMRI task in 77 healthy young and middle-aged adults.4 
Supplementary Figure E depicts this mask. The variables of years of exposure and HT-status
are inter-related for these analyses. Thus, nonparametric Wilcoxon score general linear
models6 were employed to detect an effect of either HT-status and/or years of use
simultaneously.
COGNITIVE TASK AND ANALYSES
Subjects underwent a battery of neuropsychological tests, including a verbal memory test, the
Auditory Verbal Learning test (AVLT).7 This test is similar to our fMRI task, as such was
selected for analysis. In this test, participants were read a list of fifteen words five times and
asked to recall the words after each presentation, and again after short and long delays. Age-
corrected scores were obtained using published normative data.7 As with fMRI data,
nonparametric Wilcoxon score general linear models6 were used to examine the effect of HT-
status and/or length of exposure for the three groups.
RESULTS
The accompanying Table describes subjects’ demographic, genetic, behavioral and laboratory
data. The table provides information for the three groups, HT-naïve, CEE-, and Estradiol-
exposed). The groups did not differ on any subject characteristic variable.
IMAGING RESULTS
The fMRI task evoked hippocampal and inferior temporal lobe activation bilaterally to novel
items compared to previously-learned items for all participants.
To compare the three groups of women, we used a nonparametric general linear model,
combining HT-status and years of exposure to estimate activation. Within our ROI, an effect
of HT-exposure, either CEE or estradiol-exposure was evident bilaterally in the medial
temporal lobes. Global maxima for the right was located in the body of the hippocampus
(F=6.76, p=0.003; x,y,z: 26,−20,−16; cluster size=372). For the left, global maxima was in the
ventral posterior temporal lobe (F=8.10, p=0.001; x,y,z: −36,−38,−20, cluster size=143). A
2mm radius cluster around the global maxima in the right hippocampus was selected to
represent the activation patterns for the three groups and is depicted in Figure 1. This
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representation of activation suggested that the estradiol and CEE-exposed groups exhibited the
greater neural response than the HT-naïve group.
COGNITIVE RESULTS
Age-corrected AVLT variables for the three groups were subjected to nonparametric general
linear modeling, incorporating both HT-status and years of exposure. The overall model was
significant for two of the five AVLT variables examined: the age-corrected standard scores for
the total of the learning trials and the long-delay free recall. Estimates of model-implied
expected values for each group suggested that the estradiol-exposed group exhibited the best
performance, the CEE-exposed group the worst, with the HT-naïve group intermediate to the
two. [Total of the Learning Trials F(3,19)=8.07, p=0.001; Long-Delay Free Recall F(3,19)
=6.63, p=0.003]
DISCUSSION
The mechanistic basis for estrogen’s neurobiological effects in the brain is well established
(see review3). In contrast, the WHIMS findings1, 2 revealed an increased risk for cognitive
decline and dementia with opposed CEE therapy. These surprising findings justify the need to
characterize the in vivo neurobiological actions of estrogen. To date, only one study has
examined the effects of estrogen intervention on brain activation with fMRI, finding short-
term estrogen treatment enhanced activation of the neural network underlying working
memory.8
Our comparison of women either naïve or exposed to one of two forms of HT revealed a
difference in signal change bilaterally in the medial temporal lobes, including the right
hippocampus (see Figure 1), suggesting that both forms of HT enhanced the neuronal response.
It is possible that HT-exposed women may be evidencing a compensatory increased activation;
9 however, our previous findings using this simple encoding task found increased hippocampal
signal change reflected a healthy state.4, 5
On the other hand, cognitive analyses suggested that despite their ‘healthy’ fMRI response,
women exposed to opposed CEE demonstrated worse cognitive performance compared to
women naïve to HT and those exposed to opposed estradiol. To our knowledge, these are the
first data to support the WHIMS findings of detrimental cognitive effects associated with
opposed CEE therapy. It may be that CEE is associated with hippocampal neuroprotection;
however, other cumulative effects of CEE may be detrimental. Further study with larger
samples is needed to elucidate the CNS effects of HT.
The foremost limitation with our study is the small sample size, especially for women exposed
to opposed estradiol. Furthermore, this is not a randomized trial. We were unable to control
for length of exposure to HT or other factors that may influence estrogen’s effects. Notably,
four women were on active treatment at the time of the scan, a factor that could have affected
their BOLD signal. However, excluding the four women on HT revealed a similar pattern of
neuronal activation in a more general comparison of HT-naïve and HT-exposed groups. In
total, these factors may compromise the comparability of groups and generalizability of the
data. Nonetheless, we present these data primarily to prompt further inquiry and emphasize
the urgency to clarify the differential effectiveness of various HT preparations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Area in ROI showing differential activation between three groups. Plots of cluster activation
at global maxima suggest that Estradiol and CEE-exposed groups exhibit greater signal change
than HT-naïve group. The statistical comparison is overlaid on a template brain. Orientation
for coronal slices located at y coordinates −20 to −5; the left side of the brain is on the left side
of the image. Orientation for sagittal slice is at x coordinate = 26. Smaller figure depicts
activation for three groups of women (HT-naïve, or Estradiol or CEE-exposed) represented by
eigenvalues from a 2mm radius cluster centered at maximum of right hippocampal cluster
(x,y,z: 26, −20,−16). Displayed are boxplots (min, 25th percentile, median, 75th percentile,
max, in black) superimposed on 95% confidence intervals of the medians (grey).
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Verbal Learning and Recall scores (AVLT) for women who are either HT-naïve, or Estradiol
or CEE-exposed. Displayed are boxplots (min, 25th percentile, median, 75th percentile, max,
in black) superimposed on 95% confidence intervals of the medians (grey).
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Table
Subject Characteristics
Opposed CEE Opposed Estradiol
HT Naïve (N=9) (N=10) (N=4)
Age (SD) years 58.7 (4.8) 59.9 (4.0) 54.5 (4.7)
Education (SD) years 15.9 (3.0) 16.9 (2.9) 14.5 (3.0)
BMI (SD) cm/kg 27.7 (5.6) 26.1 (6.0) 22.2 (3.1)
%ApoE 4 positive* 20.0% (1 subject) 20.0% (2 subjects) 0% (0 subjects)
fMRI Reaction time (SD) ms 0.8 (0.13) 0.8 (0.06) 0.7 (0.04)
fMRI Accuracy (SD) % correct 98.9 (2.2) 98.9 (2.0) 98.2 (2.3)
Systolic BP (SD) mmHG** 130.1 (17.3) 130.6 (15.4) 121.0 (17.1)
Diastolic BP (SD) mmHG** 81.9 (7.6) 75.6 (7.0) 77.0 (7.7)
Hemoglobin (SD) gm/dl 13.3 (1.0) 13.6 (0.6) 13.9 (1.1)
Hematocrit (SD) %RBC 39.6 (2.7) 40.6 (2.2) 40.8 (2.8)
Age initiated HT*** NA 50.6 (2.1) 47.0 (7.1)
Years used HT*** NA 6.8 (4.9) 3.5 (3.5)
*
Two subjects from HT-naïve group did not consent to ApoE testing
**
One subject’s blood pressure data were missing
***
Data on age initiated and years used HT were unavailable for 3 participants
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